Molecular signatures of secretomes from mesenchymal stem cells: therapeutic benefitsa
- Authors
- Suh, Nayoung; Subramanyam, Deepa; Lee, Mi-Young
- Issue Date
- Jun-2017
- Publisher
- 대한독성 유전단백체 학회
- Keywords
- Mesenchymal stem cell; Secretome; Molecular signature; Therapeutic benefit; Cell-free therapy
- Citation
- Molecular & Cellular Toxicology, v.13, no.2, pp 133 - 141
- Pages
- 9
- Journal Title
- Molecular & Cellular Toxicology
- Volume
- 13
- Number
- 2
- Start Page
- 133
- End Page
- 141
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7524
- DOI
- 10.1007/s13273-017-0014-9
- ISSN
- 1738-642X
2092-8467
- Abstract
- Mesenchymal stem cells (MSCs) have been extensively used in both preclinical and clinical studies for a variety of diseases and injury. Accumulating evidence indicates that paracrine function through their secretomes is considered one of the primary attributes for MSC-mediated repair and regeneration. Secretomes from MSCs include both soluble factors and factors released within extracellular vesicles (EVs). Within EVs there are selective subsets of proteins, lipids, and nucleic acids that can modulate recipient cells and disease microenvironments. In this review, we summarize the current understanding of MSC-derived secretomes at molecular and therapeutic levels, focusing on their potential as novel cell-free therapies.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medical Sciences > Department of Medical Biotechnology > 1. Journal Articles
- College of Medical Sciences > Department of Pharmaceutical Engineering > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7524)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.